| Literature DB >> 17394061 |
José Tadeu Stefano1, Claudia Pinto Marques Souza de Oliveira, Maria Lúcia Corrêa-Giannella, Vicência Mara Rodrigues de Lima, Sandra Valéria de Sá, Ellen Pierre de Oliveira, Evandro Sobroza de Mello, Daniel Giannella-Neto, Venâncio Avancini Ferreira Alves, Flair José Carrilho.
Abstract
YHK has antioxidant properties, has a hypoglycemic effect, and may reduce plasma lipid levels. In this study, we examined the hepatic expression of PPAR-alpha and -gamma and MTP in ob/ob mice receiving or not receiving YHK. Ob/ob mice were assigned to receive oral YHK (20 mg/kg/day) fed solution (methionine/choline-deficient [MCD] diet+YHK group) or vehicle (MCD group) by gavage for 4 weeks. Liver fragments were collected for histologic examination and mRNA isolation. PPAR-alpha and -gamma and MTP gene expression was examined by RT-qPCR. YHK treatment was associated with NASH prevention, weight loss, and reduction of visceral fat and of serum concentrations of aminotransferases in comparison to the MCD group. YHK promoted an increment in PPAR-alpha and MTP and a decrement in PPAR-gamma mRNA contents. These findings suggest that modulation of PPAR-alpha and -gamma and MTP RNA expression may be implicated in the protective effect of YHK in experimental NASH, limiting hepatocyte lipid accumulation.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17394061 DOI: 10.1007/s10620-007-9810-8
Source DB: PubMed Journal: Dig Dis Sci ISSN: 0163-2116 Impact factor: 3.199